Abstract
Auto-immune diseases commonly affect women of reproductive age group. These women most often need chemotherapeutic agents which may cause significant gonado-toxicity. Therefore, fertility preservation techniques must be offered to women undergoing treatment for auto-immune diseases before starting such therapy. This chapter discusses in detail the various fertility preservation techniques available with their merits and de-merits.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Katsifis GE, Tzioufas AG (2004) Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus 13(9):673–678
Austin HA, Klippel JH, Balow JE et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614–619
Hall AG, Tilby MJ (1992) Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev 6(3):163–173
Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14(5):1718–1729
Huong DLT, Amoura Z, Duhaut P et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 29:2571–2576
Mok CC, Ho CTK, Chan KW, Lau CS, Wong RWS (2002) Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum 46:1003–1013
Mok CC, Lau CS, Wong RWS (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41:831–837
Wetzels JFM (2004) Cyclophosphamide induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis? Neth J Med 62(10):347–352
Ioannidis JPA, Katsifis GE, Tzioufas AG, Moutsopoulos HM (2002) Predictors of sustained amenorrhoea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol 29:2129–2135
Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM (2010) Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat 122(3):803–811
Moore HCF, Unger JM, Phillips K-A et al (2015) Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 372:923–932
Lambertini M, Moore HCF, Robert CF et al (2018) Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol 36:1981–1990
Chen H, Xiao L, Li J, Cui L, Huang W (2019) Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 3:CD008018
Blumenfeld Z, Zur H, Dann EJ (2015) Gonadotropin-releasing hormone agonist cotreatment during chemotherapy may increase pregnancy rate in survivors. Oncologist 20(11):1283–1289
Askanase AD, Buyon JP (2002) Reproductive health in SLE. Best Pract Res Clin Rheumatol 16:265–280
Bellver J, Pellicer A (2009) Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil Steril 92(6):1803–1810
Meirow D, Levron J, Eldar-Geva T et al (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353:318–321
Oktay K, Cil AP, Bang H (2006) Efficiency of oocytes cryopreservation: a meta-analysis. Fertil Steril 86:70–80
Chian RC, Huang JY, Gilbert L et al (2009) Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril 91(6):2391–2398
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Arora, A. (2020). Fertility Preservation in Women with Autoimmune Diseases Treated with Gonadotoxic Agents. In: Sharma, S. (eds) Women's Health in Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-15-0114-2_9
Download citation
DOI: https://doi.org/10.1007/978-981-15-0114-2_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0113-5
Online ISBN: 978-981-15-0114-2
eBook Packages: MedicineMedicine (R0)